← Browse by Condition
Medical Condition
hematologic malignancies
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 1, Phase 2
NCT06823167 Phase 1
Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Enrollment
117 pts
Location
United States, Spain
Sponsor
Immunome, Inc.
NCT05470491 Phase 1, Phase 2
Recruiting
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Enrollment
265 pts
Location
United States
Sponsor
National Cancer Institute (NCI...